Amgen – Amgen weapons for quick KRAS most cancers approval because it leads race
Amgen - Amgen weapons for quick KRAS most cancers approval because it leads race Amgen has maintained its lead within ...
Home » Biotech
Amgen - Amgen weapons for quick KRAS most cancers approval because it leads race Amgen has maintained its lead within ...
AstraZeneca - BioPharma, Healthcare, healthscience, Biotechnology, BioIT, Pharma information updates INDIAN BIOSUPPLIERS MARKET GROWING AT 9% CROSSES RS 8600 CRORE ...
Sanofi - Sanofi, Evotec veteran Carter joins Fierce 15 winner Dewpoint Dewpoint Therapeutics has nabbed infectious illness specialist Kara Carter, ...
Beijing-based generic drug maker buys 15 per cent stake in Sinovac Life Sciences, a unit of Nasdaq-listed pharmaceutical agency Sinovac ...
Amgen - Amgen plans 2020 submitting for FDA approval of KRAS drug sotorasib Amgen is ready to file for FDA ...
China's Sinovac Biotech has secured US$515 million in funding from an area agency to double manufacturing capability of its ...